Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-24
1992-09-01
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, C07D41712, A01K 31425
Patent
active
051439301
ABSTRACT:
Compounds of formula (I): ##STR1## in which: A is a group of formula (II) or (III): ##STR2## W is methylene, carbonyl or >C.dbd.N--OV, where V is hydrogen, sulfo, acyl or alkyl; U is methylene, or W is absent and U is a carbon-carbon double bond between A and --CR.sup.1 (OH)--; R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are each hydrogen or alkyl; Y.sup.1 and Y.sup.2 are each hydrogen or a hydroxy-protecting group; and n is 1, 2 or 3 and salts thereof have anti-diabetic activity in mammals. Methods of preparing them are also provided.
REFERENCES:
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4873255 (1989-11-01), Yoshioka et al.
patent: 4933355 (1990-06-01), Yoshioka et al.
Fujita Takashi
Horikoshi Hiroyoshi
Kanai Tsutomu
Kinoshita Takeshi
Nakamura Kanichi
Gerstl Robert
Sankyo Company Limited
LandOfFree
Thiazolidine derivatives with anti-diabetic activity, their prep does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine derivatives with anti-diabetic activity, their prep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine derivatives with anti-diabetic activity, their prep will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-768009